Takotsubo syndrome occurring in systemic diseases: A French multicenter retrospective case-control study and literature review.

Systemic diseases Takotsubo syndrome

Journal

Autoimmunity reviews
ISSN: 1873-0183
Titre abrégé: Autoimmun Rev
Pays: Netherlands
ID NLM: 101128967

Informations de publication

Date de publication:
26 Nov 2023
Historique:
received: 06 11 2023
accepted: 22 11 2023
medline: 29 11 2023
pubmed: 29 11 2023
entrez: 28 11 2023
Statut: aheadofprint

Résumé

Describe the characteristics of patients presenting with TTS during the course of a broad spectrum of systemic diseases, in comparison to classic TTS. French multicenter retrospective case-control study completed by a literature review. 19 new cases were included in the study. The literature review identified 25 previously published cases. Among the 44 patients, 41 were females, with a median age of 67 years. The main underlying systemic diseases were systemic lupus erythematosus for seven, rheumatoid arthritis for six and primary Sjögren's syndrome for five. A TTS trigger was found in 34 cases, including a systemic disease flare-up in 28. The flare-up was treated in 15 cases, mainly with corticosteroids. One patient died during the episode, unrelated to the TTS. With a median follow-up of 24 months, all patients had recovered a normal LVEF, one had presented a recurrence of TTS, and none had died of a cardiac cause. Finally, the 19 new patients were compared with 19 classic TTS. The disease characteristics were extremely similar, with no significant difference in terms of clinical, electrocardiographic, biological and echocardiographic presentation. A broad spectrum of systemic diseases may rarely be accompanied by TTS, particularly during disease flare-ups. Although uncommon, TTS should be borne in mind in the presence of any cardiac symptomatology during the course of a systemic disease. Compared with classic TTS, their clinical, biological and echographic presentation is unremarkable. The prognosis for TTS appears to be good, with the consistent recovery of LVEF and no cardiac-related deaths.

Identifiants

pubmed: 38016574
pii: S1568-9972(23)00217-3
doi: 10.1016/j.autrev.2023.103483
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

103483

Informations de copyright

Copyright © 2023. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest No conflicts of interest needed to be disclosed by any of the authors relative to the submitted work.

Auteurs

Julien Culerrier (J)

Department of Internal Medicine, Hôpital Avicenne, AP-HP, Bobigny, France. Electronic address: julien.culerrier@aphp.fr.

Benjamin Terrier (B)

Department of Internal Medicine, Hôpital Cochin, AP-HP, Paris, France.

Matthieu Groh (M)

Department of Internal Medicine, Hôpital Foch, Suresnes, France.

Marilucy Lopez-Sublet (M)

Department of Internal Medicine, Hôpital Avicenne, AP-HP, Bobigny, France.

Benjamin De Sainte Marie (BS)

Department of Internal Medicine, Centre Hospitalier Universitaire de La Timone, Marseille, France.

Géraldine Falgarone (G)

Department of Rheumatology, Hôpital Avicenne, AP-HP, Bobigny, France.

Olivier Lidove (O)

Department of Internal Medicine, Hôpital de la Croix St Simon, Paris, France.

Patrick Mercie (P)

Department of Internal Medicine, Hôpital Saint-André, Bordeaux, France.

Luc Mouthon (L)

Department of Internal Medicine, Hôpital Cochin, AP-HP, Paris, France.

Christophe Meune (C)

Department of Cardiology, Hôpital Avicenne, AP-HP, Bobigny, France.

Robin Dhote (R)

Department of Internal Medicine, Hôpital Avicenne, AP-HP, Bobigny, France.

Classifications MeSH